ERLI PLUS 12.5 1000MG TAB 14s

ERLI PLUS combines Erlotinib with another therapeutic agent (12.5/1000mg) for enhanced cancer treatment efficacy. Designed for advanced NSCLC cases requiring combination therapy.

Benefits:

• Provides synergistic effect with dual therapy.

• Helps slow progression of cancer.

SEO Tags:
#ERLIPLUS #ErlotinibCombination #CancerMedication #NSCLCTreatment #AdvancedCancerCare